Why the study?
To determine the impact of multiday heart rate variability on the risk of MACE, heart failure, and mortality in people at high risk of diabetes.
Is lower multiday heart rate variability associated with an increased risk of MACE, heart failure, and all-cause mortality in people at high risk of diabetes?
Is lower multiday heart rate variability associated with an increased risk of MACE, heart failure, and all-cause mortality in people at high risk of diabetes?
Cardiovascular autonomic dysfunction, indicated by lower multiday heart rate variability, is a significant predictor of MACE, heart failure, and all-cause mortality in individuals at high risk for diabetes.
Authors
No takes yet. Share an insight, caveat, or question.
Lower multiday HRV was associated with higher MACE, HF and mortality risk; leaves open incremental prognostic value in high-diabetes-risk cohorts.
Schaarup et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: